KCNJ2 Antikörper (C-Term)
Kurzübersicht für KCNJ2 Antikörper (C-Term) (ABIN1107936)
Target
Alle KCNJ2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- This antibody reacts with 48 kDa Kir2.1 protein.
-
Kreuzreaktivität (Details)
-
Species reactivity (expected):Mouse and Rat.
Species reactivity (tested):Human. -
Aufreinigung
- Purified
-
Immunogen
- Synthetic peptide derived from C-term domain of human Kir2.1
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- K2HPO4/KH2PO4, Glycerol 50 % , ( pH 7.5)
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
-
: "Initiation of human myoblast differentiation via dephosphorylation of Kir2.1 K+ channels at tyrosine 242." in: Development (Cambridge, England), Vol. 135, Issue 5, pp. 859-67, (2008) (PubMed).
-
-
- KCNJ2 (Potassium Inwardly-Rectifying Channel, Subfamily J, Member 2 (KCNJ2))
-
Andere Bezeichnung
- KCNJ2
-
Hintergrund
- Synonyms: Cardiac inward rectifier potassium channel, HIRK1, IRK1, Inward rectifier K(+) channel Kir2.1, Inward rectifier potassium channel 2, KCNJ2, Potassium channel, inwardly rectifying subfamily J member 2
-
Gen-ID
- 3759
-
NCBI Accession
- NP_000882
Target
-